fbpx
https://blog.euromonitor.com/wp-content/uploads/2018/05/iconEMICroppedSquare-150x150.png

By: Mark Strobel

2014 marks a highly eventful year for the US over-the-counter (OTC) remedies market. Among the most influential trends are the shifting competitive landscape as a result of mergers and acquisitions, the continued success of recovering brands post manufacturing disruptions leading to a decline in private label share, and prescription to OTC switches making a strong splash in the market and breathing life into what have been sluggish OTC categories.

About Our Research

Request a complimentary demonstration of our award-winning market research today.